Literature DB >> 25125715

A novel T cell evasion mechanism in persistent RNA virus infection.

Jack T Stapleton1, Jinhua Xiang1, James H McLinden1, Nirjal Bhattarai1, Ernest T Chivero1, Donna Klinzman1, Thomas M Kaufman1, Qing Chang1.   

Abstract

Hepatitis C virus (HCV) and GB virus type C (GBV-C) are associated with impaired T cell function despite the fact that HCV replicates in hepatocytes and GBV-C in a small proportion of lymphocytes. Recently, we showed that HCV and GBV-C E2-envelope proteins reduce T cell activation via the T cell receptor (TCR) by competing for phosphorylation with a critical kinase in the TCR signaling cascade (Lck). E2 interfered with TCR signaling in E2 expressing cells and in bystander cells. The bystander effect was mediated by virus particles and extracellular microvesicular particles (exosomes). Multiple kinase substrate sites are predicted to reside on viral structural proteins and based on bioinformatic predictions, many RNA virus pathogens may interfere with TCR signaling via a similar mechanism. Identification of T cell inhibitory effects of virus structural proteins may provide novel approaches to enhance the immunogenicity and memory of viral vaccines.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25125715      PMCID: PMC4112695     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


  28 in total

Review 1.  GB virus type C: a beneficial infection?

Authors:  Jack T Stapleton; Carolyn F Williams; Jinhua Xiang
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

2.  Immunization with hepatitis C virus core gene triggers potent T-cell response, but affects CD4+ T-cells.

Authors:  Maria G Isaguliants; Natalia V Petrakova; Elena V Kashuba; Yulia G Suzdaltzeva; Sergey V Belikov; Vladislav V Mokhonov; Alexei G Prilipov; Ludmila Matskova; Irina S Smirnova; Colette Jolivet-Reynaud; Erik Nordenfelt
Journal:  Vaccine       Date:  2004-04-16       Impact factor: 3.641

Review 3.  Hepatitis C: the clinical spectrum of disease.

Authors:  J H Hoofnagle
Journal:  Hepatology       Date:  1997-09       Impact factor: 17.425

4.  Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group.

Authors:  B J Pereira; S N Natov; B A Bouthot; B V Murthy; R Ruthazer; C H Schmid; A S Levey
Journal:  Kidney Int       Date:  1998-05       Impact factor: 10.612

Review 5.  Adaptive immune responses in acute and chronic hepatitis C virus infection.

Authors:  David G Bowen; Christopher M Walker
Journal:  Nature       Date:  2005-08-18       Impact factor: 49.962

6.  Effect of early and late GB virus C viraemia on survival of HIV-infected individuals: a meta-analysis.

Authors:  W Zhang; K Chaloner; H L Tillmann; C F Williams; J T Stapleton
Journal:  HIV Med       Date:  2006-04       Impact factor: 3.180

7.  GPS 2.0, a tool to predict kinase-specific phosphorylation sites in hierarchy.

Authors:  Yu Xue; Jian Ren; Xinjiao Gao; Changjiang Jin; Longping Wen; Xuebiao Yao
Journal:  Mol Cell Proteomics       Date:  2008-05-06       Impact factor: 5.911

8.  Regulation of CC chemokine receptor 5 in hepatitis G virus infection.

Authors:  Jacob Nattermann; Hans-Dieter Nischalke; Bernd Kupfer; Jürgen Rockstroh; Lothar Hess; Tilman Sauerbruch; Ulrich Spengler
Journal:  AIDS       Date:  2003-07-04       Impact factor: 4.177

9.  GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy.

Authors:  Jack T Stapleton; Kathryn Chaloner; Jingyang Zhang; Donna Klinzman; Inara E Souza; Jinhua Xiang; Alan Landay; John Fahey; Richard Pollard; Ronald Mitsuyasu
Journal:  AIDS       Date:  2009-03-13       Impact factor: 4.177

Review 10.  Subversion of immune responses by hepatitis C virus: immunomodulatory strategies beyond evasion?

Authors:  Young S Hahn
Journal:  Curr Opin Immunol       Date:  2003-08       Impact factor: 7.486

View more
  9 in total

Review 1.  Tropism of human pegivirus (formerly known as GB virus C/hepatitis G virus) and host immunomodulation: insights into a highly successful viral infection.

Authors:  Ernest T Chivero; Jack T Stapleton
Journal:  J Gen Virol       Date:  2015-02-09       Impact factor: 3.891

2.  Human Hepegivirus-1: Innocent Traveler, Helpful Symbiote, or Insidious Pathogen?

Authors:  Abraham J Kandathil; Ashwin Balagopal
Journal:  Clin Infect Dis       Date:  2020-08-22       Impact factor: 9.079

3.  Durable sequence stability and bone marrow tropism in a macaque model of human pegivirus infection.

Authors:  Adam L Bailey; Michael Lauck; Mariel Mohns; Eric J Peterson; Kerry Beheler; Kevin G Brunner; Kristin Crosno; Andres Mejia; James Mutschler; Matthew Gehrke; Justin Greene; Adam J Ericsen; Andrea Weiler; Gabrielle Lehrer-Brey; Thomas C Friedrich; Samuel D Sibley; Esper G Kallas; Saverio Capuano; Jeffrey Rogers; Tony L Goldberg; Heather A Simmons; David H O'Connor
Journal:  Sci Transl Med       Date:  2015-09-16       Impact factor: 17.956

4.  Arteriviruses, Pegiviruses, and Lentiviruses Are Common among Wild African Monkeys.

Authors:  Adam L Bailey; Michael Lauck; Ria R Ghai; Chase W Nelson; Katelyn Heimbruch; Austin L Hughes; Tony L Goldberg; Jens H Kuhn; Anna J Jasinska; Nelson B Freimer; Cristian Apetrei; David H O'Connor
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

Review 5.  Human pegivirus detected in a patient with severe encephalitis using a metagenomic pan-virus array.

Authors:  Helena Fridholm; Line Østergaard Sørensen; Maiken W Rosenstierne; Henrik Nielsen; Finn Sellebjerg; Åse Bengård Andersen; Anders Fomsgaard
Journal:  J Clin Virol       Date:  2016-01-29       Impact factor: 3.168

6.  Role of human Pegivirus infections in whole Plasmodium falciparum sporozoite vaccination and controlled human malaria infection in African volunteers.

Authors:  Anneth-Mwasi Tumbo; Tobias Schindler; Jean-Pierre Dangy; Nina Orlova-Fink; Jose Raso Bieri; Maximillian Mpina; Florence A Milando; Omar Juma; Ali Hamad; Elizabeth Nyakarungu; Mwajuma Chemba; Ali Mtoro; Kamaka Ramadhan; Ally Olotu; Damas Makweba; Stephen Mgaya; Kenneth Stuart; Matthieu Perreau; Jack T Stapleton; Said Jongo; Stephen L Hoffman; Marcel Tanner; Salim Abdulla; Claudia Daubenberger
Journal:  Virol J       Date:  2021-01-26       Impact factor: 4.099

Review 7.  Review of human pegivirus: Prevalence, transmission, pathogenesis, and clinical implication.

Authors:  Yaqi Yu; Zhenzhou Wan; Jian-Hua Wang; Xianguang Yang; Chiyu Zhang
Journal:  Virulence       Date:  2022-12       Impact factor: 5.882

8.  Pegivirus avoids immune recognition but does not attenuate acute-phase disease in a macaque model of HIV infection.

Authors:  Adam L Bailey; Connor R Buechler; Daniel R Matson; Eric J Peterson; Kevin G Brunner; Mariel S Mohns; Meghan Breitbach; Laurel M Stewart; Adam J Ericsen; Christina M Newman; Michelle R Koenig; Emma Mohr; John Tan; Saverio Capuano; Heather A Simmons; David T Yang; David H O'Connor
Journal:  PLoS Pathog       Date:  2017-10-26       Impact factor: 6.823

9.  Infective respiratory syncytial virus is present in human cord blood samples and most prevalent during winter months.

Authors:  Angela Mary Fonceca; Abha Chopra; Avram Levy; Paul Stanton Noakes; Matthew Wee-Peng Poh; Natasha Leanne Bear; Susan Prescott; Mark Lloyd Everard
Journal:  PLoS One       Date:  2017-04-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.